Search

Search Constraints

You searched for: Author/Creator Perno, C.F.

Search Results

1. A close monitoring of virological and immunological hepatitis B markers can improve the diagnosis of HBV reactivation in HBsAg-negative/anti-HBc-positive patients with oncohematological diseases. (February 2019)

2. A high HBsAg genetic complexity can influence HBV immunogenicity in the setting of acute infection. (15th February 2015)

3. A hyper-glycosylation of HBV surface major hydrophilic region correlates with immunosuppression-driven HBV reactivation and hampers HBsAg recognition in vitro. (15th February 2015)

4. A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy. (December 2015)

5. An elevated degree of genetic variability characterizes Hepatitis Delta Antigen (HDAg) and correlates with high levels of serum HDV-RNA: Implication for disease progression and design of new pharmacological targets. Issue 1 (16th February 2017)

6. Analysis of resistance and phylogenetic clusters in HCV-2c infected patients within the Italian network Vironet C. (February 2020)

7. Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study. (21st January 2016)

8. Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance. (February 2019)

9. Characterization of resistance profiles in HCV 2-3-4 DAA-naïve and DAA-experienced infected patients in Italy. Issue 1 (February 2018)

10. Clinical relevance of accurate HCV genotype and subtype assignment by NS3/NS5A/NS5B direct sequencing in the era of new direct acting antiviral agents. (10th February 2016)